A carregar...
Implementing TMB measurement in clinical practice: considerations on assay requirements
Clinical evidence demonstrates that treatment with immune checkpoint inhibitor immunotherapy agents can have considerable benefit across multiple tumours. However, there is a need for the development of predictive biomarkers that identify patients who are most likely to respond to immunotherapy. Com...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350758/ https://ncbi.nlm.nih.gov/pubmed/30792906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000442 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|